Cargando…

Systematic Correlation Analyses of Circulating Tumor Cells with Clinical Variables and Tumor Markers in Lung Cancer Patients

Measurement of circulating tumor cells (CTC) offers promise as a clinical biomarker to monitor disease status, therapeutic response, and progression in cancer patients. However, its clinical value in lung cancer patients has not been fully explored. We systematically evaluate the association of CTCs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xu, Ma, Kewei, Yang, Zhiguang, Cui, Jiuwei, He, Hua, Hoffman, Andrew R., Hu, Ji-Fan, Li, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604461/ https://www.ncbi.nlm.nih.gov/pubmed/28928901 http://dx.doi.org/10.7150/jca.18032

Ejemplares similares

Clinical significance of circulating tumor cells and tumor markers in the diagnosis of lung cancer
por: Li, Yang, et al.
Publicado: (2019)

The Value of Circulating Tumor Cells and Tumor Markers Detection in Lung Cancer Diagnosis
por: Guo, Sumin, et al.
Publicado: (2023)

The Efficacy of Different Inflammatory Markers for the Prognosis of Patients with Malignant Tumors
por: Zheng, Kaiwen, et al.
Publicado: (2021)

Combining Telomerase Reverse Transcriptase Genetic Variant rs2736100 with Epidemiologic Factors in the Prediction of Lung Cancer Susceptibility
por: Wang, Xu, et al.
Publicado: (2016)

Single-cell analyses of circulating tumor cells
por: Chen, Xi-Xi, et al.
Publicado: (2015)

Knockdown of COPS3 Inhibits Lung Cancer Tumor Growth in Nude Mice by Blocking Cell Cycle Progression
por: Pang, Jianan, et al.
Publicado: (2017)

Enrichment of Circulating Tumor Cells of Lung Cancer and Correlation With Serum Leukomonocyte and Tumor Biomarkers: A Retrospective Study
por: Mei, Zhou-Fang, et al.
Publicado: (2023)

CRISPR Cas9-guided chromatin immunoprecipitation identifies miR483 as an epigenetic modulator of IGF2 imprinting in tumors
por: Zhang, Yiqun, et al.
Publicado: (2016)

Circulating Tumor DNA Analyses as a Potential Marker of Recurrence and Effectiveness of Adjuvant Chemotherapy for Resected Non-Small-Cell Lung Cancer
por: Kuang, Peng-Peng, et al.
Publicado: (2021)

Prospects for Comprehensive Analyses of Circulating Tumor Cells in Tumor Biology
por: Aoki, Masahiko, et al.
Publicado: (2020)

Combination of Circulating Tumor Cells with Serum Carcinoembryonic Antigen Enhances Clinical Prediction of Non-Small Cell Lung Cancer
por: Chen, Xi, et al.
Publicado: (2015)

Single-cell analyses identify circulating anti-tumor CD8 T cells and markers for their enrichment
por: Pauken, Kristen E., et al.
Publicado: (2021)

Circulating Tumor Cell Analyses in Patients With Esophageal Squamous Cell Carcinoma Using Epithelial Marker-Dependent and -Independent Approaches
por: Li, Hao, et al.
Publicado: (2015)

Cancer Stem Cell Marker Musashi-1 rs2522137 Genotype Is Associated with an Increased Risk of Lung Cancer
por: Wang, Xu, et al.
Publicado: (2014)

Molecular Biomarker Analyses Using Circulating Tumor Cells
por: Punnoose, Elizabeth A., et al.
Publicado: (2010)

Correlation of circulating tumor DNA EGFR mutation levels with clinical outcomes in patients with advanced lung adenocarcinoma
por: Liu, Xiang-Liang, et al.
Publicado: (2021)

Circulating Tumor Cell and Cell-free Circulating Tumor DNA in Lung Cancer
por: Nurwidya, Fariz, et al.
Publicado: (2016)

Mouse double minute-2 homolog (MDM2)-rs2279744 polymorphism associated with lung cancer risk in a Northeastern Chinese population
por: Wang, Xu, et al.
Publicado: (2015)

Circulating Tumor Cells as a Screening and Diagnostic Marker for Early-Stage Non-Small Cell Lung Cancer
por: Duan, Guo-Chen, et al.
Publicado: (2020)

Analysis of tumor markers in pleural effusion and serum to verify the correlations between serum tumor markers and tumor size, TNM stage of lung adenocarcinoma
por: Chen, Zhongqing, et al.
Publicado: (2019)

Development of Immunotherapy Strategies Targeting Tumor Microenvironment Is Fiercely Ongoing
por: Bai, Rilan, et al.
Publicado: (2022)

Eukaryotic translation initiation factor eIF4G2 opens novel paths for protein synthesis in development, apoptosis and cell differentiation
por: Liu, Yudi, et al.
Publicado: (2022)

Can Circulating Cell-Free DNA or Circulating Tumor DNA Be a Promising Marker in Ovarian Cancer?
por: Yu, Ming, et al.
Publicado: (2021)

Detection of circulating tumor cells in patients with pituitary tumors
por: Hua, Gao, et al.
Publicado: (2018)

Detection of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer()
por: Zheng, Xiumei, et al.
Publicado: (2017)

Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as a Liquid Biopsy Marker in Colorectal Cancer
por: Heidrich, Isabel, et al.
Publicado: (2021)

Expression of MET in circulating tumor cells correlates with expression in tumor tissue from advanced-stage lung cancer patients
por: Ilie, Marius, et al.
Publicado: (2017)

Circulating tumor cells with epithelial-mesenchymal transition markers as potential biomarkers for the diagnosis of lung cancer
por: Jiang, Sha-Sha, et al.
Publicado: (2021)

Molecular and Kinetic Analyses of Circulating Tumor Cells as Predictive Markers of Treatment Response in Locally Advanced Rectal Cancer Patients
por: Troncarelli Flores, Bianca C., et al.
Publicado: (2019)

Circulating tumor cells (CTCs)/circulating tumor endothelial cells (CTECs) and their subtypes in small cell lung cancer: Predictors for response and prognosis
por: Zhu, Hao‐Hua, et al.
Publicado: (2021)

The combination of folate receptor-positive circulating tumor cells and serum tumor markers suggests a histological diagnosis of lung cancer
por: Lv, Xing, et al.
Publicado: (2022)

Challenges of evaluating immunotherapy efficacy in solid tumors
por: Bai, Rilan, et al.
Publicado: (2019)

Nerves in the Tumor Microenvironment: Origin and Effects
por: Wang, Wenjun, et al.
Publicado: (2020)

Survivin-positive circulating tumor cells as a marker for metastasis of hepatocellular carcinoma
por: Yu, Jing, et al.
Publicado: (2021)

Circulating tumor cells as a prognostic and predictive marker in gastrointestinal stromal tumors: a prospective study
por: Li, Qiang, et al.
Publicado: (2016)

A retrospective diagnostic test study on circulating tumor cells and artificial intelligence imaging in patients with lung adenocarcinoma
por: Ma, Minjie, et al.
Publicado: (2022)

Circulating tumor DNA as a therapy response marker in metastatic colorectal cancer
por: Ma, Xiaoju Max, et al.
Publicado: (2022)

Association of Metabolic, Inflammatory, and Tumor Markers With Circulating Tumor Cells in Metastatic Breast Cancer
por: Lohmann, Ana Elisa, et al.
Publicado: (2018)

The Nucleus/Mitochondria-Shuttling LncRNAs Function as New Epigenetic Regulators of Mitophagy in Cancer
por: Li, Yan, et al.
Publicado: (2021)

Correlation analysis of circulating tumor cells and Claudin-4 in breast cancer
por: Chai, Jie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4ja8une3snl87ei2966hq0lfph